Stone Ridge Asset Management LLC Biogen Inc. Transaction History

Stone Ridge Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $1.63 Million - $2.54 Million	-7,500 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $3.52 Million - $4.61 Million	-12,000 Reduced 61.54%	7,500 $2.65 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $3.09 Million - $3.68 Million	12,000 Added 160.0%	19,500 $5.66 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $182,091 - $257,537	-700 Reduced 8.54%	7,500 $2.05 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $2.52 Million - $2.83 Million	8,200	8,200 $2.61 Million

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.